Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of COVID-19 Recombinant Protein Vaccine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of COVID-19 Recombinant Protein Vaccinemarket, defines the market attractiveness level of COVID-19 Recombinant Protein Vaccine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of COVID-19 Recombinant Protein Vaccine industry, describes the types of COVID-19 Recombinant Protein Vaccine market, the applications of major players and the market size, and deeply analyzes the current situation of the global COVID-19 Recombinant Protein Vaccine market and the development prospects and opportunities of COVID-19 Recombinant Protein Vaccine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global COVID-19 Recombinant Protein Vaccine market in Chapter 13.
By Player:
Johnson & Johnson
Clover Biopharmaceuticals
Sanofi
Suzhou Yuzhibo Biotechnology
GSK
Pukang Biologic Technology
Novavax
By Type:
Being Developed
Preclinical
Clinical I
Clinical II
By End-User:
Pharmaceutical And Biotechnology Companies
Hospital
Academic And Research Organizations
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 COVID-19 Recombinant Protein Vaccine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 COVID-19 Recombinant Protein Vaccine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 COVID-19 Recombinant Protein Vaccine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 COVID-19 Recombinant Protein Vaccine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise COVID-19 Recombinant Protein Vaccine Market Analysis and Outlook to 2022
-
7.1 Global COVID-19 Recombinant Protein Vaccine Consumption (2017-2022)
-
7.2 United States COVID-19 Recombinant Protein Vaccine Consumption (2017-2022)
-
7.3 Europe COVID-19 Recombinant Protein Vaccine Consumption (2017-2022)
-
7.4 China COVID-19 Recombinant Protein Vaccine Consumption (2017-2022)
-
7.5 Japan COVID-19 Recombinant Protein Vaccine Consumption (2017-2022)
-
7.6 India COVID-19 Recombinant Protein Vaccine Consumption (2017-2022)
-
7.7 South Korea COVID-19 Recombinant Protein Vaccine Consumption (2017-2022)
8 Region and Country-wise COVID-19 Recombinant Protein Vaccine Market Analysis and Outlook to 2028
-
8.1 Global COVID-19 Recombinant Protein Vaccine Consumption Forecast (2022-2028)
-
8.2 United States COVID-19 Recombinant Protein Vaccine Consumption Forecast (2022-2028)
-
8.3 Europe COVID-19 Recombinant Protein Vaccine Consumption Forecast (2022-2028)
-
8.4 China COVID-19 Recombinant Protein Vaccine Consumption Forecast (2022-2028)
-
8.5 Japan COVID-19 Recombinant Protein Vaccine Consumption Forecast (2022-2028)
-
8.6 India COVID-19 Recombinant Protein Vaccine Consumption Forecast (2022-2028)
-
8.7 South Korea COVID-19 Recombinant Protein Vaccine Consumption Forecast (2022-2028)
9 Global COVID-19 Recombinant Protein Vaccine Market Outlook by Types and Applications to 2022
-
9.1 Global COVID-19 Recombinant Protein Vaccine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Being Developed Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Preclinical Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Clinical I Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Clinical II Consumption and Growth Rate (2017-2022)
-
9.2 Global COVID-19 Recombinant Protein Vaccine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Pharmaceutical And Biotechnology Companies Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Academic And Research Organizations Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global COVID-19 Recombinant Protein Vaccine Market Outlook by Types and Applications to 2028
-
10.1 Global COVID-19 Recombinant Protein Vaccine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Being Developed Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Preclinical Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Clinical I Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Clinical II Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global COVID-19 Recombinant Protein Vaccine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Pharmaceutical And Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Academic And Research Organizations Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global COVID-19 Recombinant Protein Vaccine Import and Export Analysis (Top 5 Countries)
-
11.1 Global COVID-19 Recombinant Protein Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global COVID-19 Recombinant Protein Vaccine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 COVID-19 Recombinant Protein Vaccine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global COVID-19 Recombinant Protein Vaccine Market Competitive Analysis
-
14.1 Johnson & Johnson
-
14.1.1 Johnson & Johnson Company Details
-
14.1.2 Johnson & Johnson COVID-19 Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Johnson & Johnson COVID-19 Recombinant Protein Vaccine Product and Service
-
14.2 Clover Biopharmaceuticals
-
14.2.1 Clover Biopharmaceuticals Company Details
-
14.2.2 Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Product and Service
-
14.3 Sanofi
-
14.3.1 Sanofi Company Details
-
14.3.2 Sanofi COVID-19 Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Sanofi COVID-19 Recombinant Protein Vaccine Product and Service
-
14.4 Suzhou Yuzhibo Biotechnology
-
14.4.1 Suzhou Yuzhibo Biotechnology Company Details
-
14.4.2 Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Product and Service
-
14.5 GSK
-
14.5.1 GSK Company Details
-
14.5.2 GSK COVID-19 Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GSK COVID-19 Recombinant Protein Vaccine Product and Service
-
14.6 Pukang Biologic Technology
-
14.6.1 Pukang Biologic Technology Company Details
-
14.6.2 Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Product and Service
-
14.7 Novavax
-
14.7.1 Novavax Company Details
-
14.7.2 Novavax COVID-19 Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Novavax COVID-19 Recombinant Protein Vaccine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of COVID-19 Recombinant Protein Vaccine
-
Figure COVID-19 Recombinant Protein Vaccine Picture
-
Table Global COVID-19 Recombinant Protein Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global COVID-19 Recombinant Protein Vaccine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global COVID-19 Recombinant Protein Vaccine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global COVID-19 Recombinant Protein Vaccine Consumption by Country (2017-2022)
-
Figure United States COVID-19 Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)
-
Table Europe COVID-19 Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)
-
Figure China COVID-19 Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Japan COVID-19 Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)
-
Figure India COVID-19 Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)
-
Figure South Korea COVID-19 Recombinant Protein Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global COVID-19 Recombinant Protein Vaccine Consumption Forecast by Country (2022-2028)
-
Figure United States COVID-19 Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe COVID-19 Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China COVID-19 Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan COVID-19 Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India COVID-19 Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea COVID-19 Recombinant Protein Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Being Developed Consumption and Growth Rate (2017-2022)
-
Figure Global Preclinical Consumption and Growth Rate (2017-2022)
-
Figure Global Clinical I Consumption and Growth Rate (2017-2022)
-
Figure Global Clinical II Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical And Biotechnology Companies Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Academic And Research Organizations Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Being Developed Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Preclinical Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinical I Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinical II Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical And Biotechnology Companies Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Academic And Research Organizations Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global COVID-19 Recombinant Protein Vaccine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global COVID-19 Recombinant Protein Vaccine Export by Region (Top 5 Countries) (2017-2028)
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson COVID-19 Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson COVID-19 Recombinant Protein Vaccine Product and Service
-
Table Clover Biopharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clover Biopharmaceuticals COVID-19 Recombinant Protein Vaccine Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi COVID-19 Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi COVID-19 Recombinant Protein Vaccine Product and Service
-
Table Suzhou Yuzhibo Biotechnology (Foundation Year, Company Profile and etc.)
-
Table Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Suzhou Yuzhibo Biotechnology COVID-19 Recombinant Protein Vaccine Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK COVID-19 Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK COVID-19 Recombinant Protein Vaccine Product and Service
-
Table Pukang Biologic Technology (Foundation Year, Company Profile and etc.)
-
Table Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pukang Biologic Technology COVID-19 Recombinant Protein Vaccine Product and Service
-
Table Novavax (Foundation Year, Company Profile and etc.)
-
Table Novavax COVID-19 Recombinant Protein Vaccine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novavax COVID-19 Recombinant Protein Vaccine Product and Service
-
